Publication | Open Access

A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407

Protocol-specified Final AnalysisMedicinePembrolizumab Plus ChemotherapyClinical TrialsMetastatic Squamous NsclcImmune Checkpoint InhibitorPharmacotherapyCancer TreatmentOncologyRadiation OncologyLung CancerHealth Sciences